World Orphan Drug Congress Europe
23 – 25 October, 2024 // Barcelona, Spain
Join Worldwide Clinical Trials at World Orphan Drug Congress Europe.
33
days leftAbout event
WODC is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. If you are attending, stop by booth #30 and say hello to our team.
Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, will be presenting Bridging the Gap: Clinical Trials as a Standard of Care in Rare Diseases on 23 October at 2:10 P.M CEST.
Derek Ansel, Vice President, Therapeutic Strategy Lead, Rare Disease, will be in a Working Group, that is scheduled for 23 October at 11:30 A.M. CEST titled, Shifting Strands: Operational Challenges and Ethical Dilemmas of Genetic Testing.
Date
Wednesday to Friday
23 – 25 October, 2024
Venue
Fira de Barcelona Montjuic
Av. de la Reina Maria Cristina, s/n, Sants-Montjuïc, 08004 Barcelona, Spain
Nathan Chadwick
Senior Director, Therapeutic Strategy Lead, Rare Disease
With more than a decade of dedicated experience in clinical research, Nathan Chadwick is well-versed in several therapeutic areas, with a specialized focus in neurology and rare disease. At Worldwide, Nathan is at the forefront of therapeutic strategy for rare disease, leading ongoing efforts with rare disease patient advocacy organizations while working to expand rare disease opportunities, studies, and initiatives.
